Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиOcuphire Pharma Мультипликаторы 2011-2024 | OCUP
Мультипликаторы по годам Ocuphire Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.5 | 4.2 | -0.8 | -2.4 | -9.3 | - | - | - | - | - | - | - | - |
P/S |
2.3 | 1.9 | 79.9 | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.5 | 0.9 | -3.8 | -5.3 | -2.2 | -0.4 | -0.9 | -0.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
EV (Enterprise Value) |
-1.98 млн | 34.7 млн | 26.4 млн | 73.1 млн | 65.4 млн | -8.74 млн | -8.9 млн | -11.6 млн | -10.2 млн | -9.83 млн | -18.7 млн | -13.5 млн | -9.86 млн |
EBITDA per Share |
-0.49 | 0.91 | -1.53 | -1.89 | -0.6 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-1.1 | -5.0 | -13.2 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.01 | 10.73 | - | - | - | - | - | - | - | - | ||
P/B |
0.9 | 1.6 | 2.1 | -4.3 | -7.6 | - | - | - | - | - | - | - | - |
P/CF |
-40.0 | 5.2 | -2.4 | -8.6 | -15.9 | - | - | - | - | - | - | - | - |
ROE % |
-20.01 | 38.69 | -255.12 | 182.82 | 81.60 | - | - | - | - | - | - | - | - |
ROA % |
-18.51 | 36.51 | -217.41 | -139.24 | -345.80 | - | - | - | - | - | - | - | - |
ROCE % |
-21.17 | 39.42 | -102.17 | -65.30 | 55.46 | - | - | - | - | - | - | - | - |
Current Ratio |
13.3 | 17.8 | 6.8 | 5.5 | 0.2 | - | - | - | - | - | - | - | - |
DSO |
21.3 | 5.9 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
21.3 | 5.9 | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
21.3 | 5.9 | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Ocuphire Pharma
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.26 | -0.24 | -0.28 | - | -0.22 | -0.25 | -0.35 | - | -0.25 | -0.52 | -3.57 | - | -0.33 | -0.43 | -0.87 | - | -0.49 | -0.61 | -0.62 | -0.09 | -2.02 | -0.12 | -0.79 | -0.12 | -0.04 | 0.04 | -0.91 | -0.02 | -0.13 | -0.08 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | - | -0.09 | - | -0.02 | -0.03 | -0.01 | - | -0.03 | -0.01 | -0.02 | - | -0.02 | -0.06 | -0.05 |
EBITDA per Share |
0.3 | -0.26 | -0.29 | - | -0.22 | -0.25 | -0.34 | - | -0.25 | -0.52 | -0.47 | - | -0.52 | -0.34 | -0.77 | - | -0.56 | -0.74 | -1.04 | -1.59 | -1.76 | -0.16 | -2.22 | -0.15 | -0.15 | -0.16 | -0.17 | -0.17 | -0.17 | -0.18 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | - | -0.01 | -0.02 | -0.02 | - | -0.02 | -0.02 | -0.02 | - | -0.04 | -0.07 | -0.05 |
ROE % |
-54.29 | -103.50 | -124.10 | -110.09 | -130.66 | -113.08 | -110.96 | -449.66 | -440.39 | -410.56 | -367.01 | 44.11 | 24.43 | -4.51 | -41.17 | -67.95 | 115.48 | 84.62 | 73.03 | 76.91 | -127.95 | -83.59 | -41.61 | -150.84 | -132.50 | -143.12 | -159.12 | -54.56 | -66.67 | -71.31 | -78.18 | -76.61 | -69.74 | -55.46 | -37.50 | -69.68 | -78.32 | -88.11 | -113.47 | -53.70 | -85.05 | -99.45 | -85.76 | -64.73 | -78.45 | -60.82 | -104.33 | -109.60 | -13.72 | -54.44 | -41.44 |
ROA % |
-45.01 | -86.37 | -102.49 | -90.82 | -109.05 | -96.18 | -96.91 | -368.23 | -375.29 | -364.11 | -344.93 | -33.59 | -48.70 | -56.75 | -66.68 | -52.18 | -71.60 | -89.77 | -94.70 | -89.56 | -82.84 | -53.23 | -25.95 | -89.42 | -79.22 | -89.17 | -100.91 | -44.23 | -53.23 | -55.84 | -60.49 | -57.99 | -53.08 | -42.53 | -28.91 | -55.23 | -59.59 | -64.86 | -81.33 | -34.67 | -54.70 | -63.79 | -54.88 | -41.36 | -52.10 | -42.79 | -78.39 | -85.72 | -10.73 | -42.58 | -32.41 |
ROCE % |
-54.66 | -105.57 | -125.11 | -109.72 | -130.30 | -112.67 | -110.48 | -105.06 | -90.59 | -55.55 | -14.53 | 44.14 | 21.24 | -16.13 | -55.51 | -92.46 | 199.86 | 178.42 | 161.08 | 144.90 | -176.62 | -157.44 | -135.64 | -103.50 | -97.26 | -93.89 | -91.28 | -96.22 | -96.50 | -99.52 | -102.26 | -97.27 | -88.51 | -75.51 | -63.04 | -49.92 | -49.87 | -52.50 | -54.45 | -44.72 | -63.60 | -68.03 | -72.27 | -58.03 | -89.37 | -101.83 | -142.76 | -128.22 | -31.34 | -60.33 | -36.55 |
Current Ratio |
13.9 | 7.5 | 10.9 | 17.8 | 5.4 | 5.4 | 6.4 | 6.8 | 8.8 | 9.4 | 5.2 | 0.6 | 0.6 | 0.6 | 0.6 | 0.2 | 4.3 | 4.3 | 4.3 | 2.9 | 2.9 | 2.9 | 2.9 | 2.5 | 2.5 | 2.5 | 2.5 | 5.3 | 5.3 | 5.3 | 5.3 | 4.1 | 4.1 | 4.1 | 4.1 | 4.8 | 4.8 | 4.8 | 4.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 4.6 | 4.6 | 4.6 | 4.6 |
DSO |
39.2 | 36.9 | 107.8 | - | - | - | - | - | 4.7 | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
39.2 | 36.9 | 107.8 | - | - | - | - | - | 4.7 | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
39.2 | 36.9 | 107.8 | - | - | - | - | - | 4.7 | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD